3Kung AW, Michon J, Tai KS, et al. The effect of somatostatin versus corticosteroid in the treatment of Graves' ophthalmopathy[ J ]. Thyroid,1996,6(5) :381-384.
4Bartalena L, Mareocci C, Bogazzi F, et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy[ J]. N Engl J Med, 1998,338(2) :73-78.
5Hatton MP, Rubin PA. The pathophysiology of thyroid-associated ophythalmopathy[ J ]. Ophthalmol Clin North Am, 2002, 15 ( 1 ) : 113-119.
6Perros P, Crombie AL, Kendall-Taylor P. Natural history of thyroid-associated ophthalmopathy[ J]. J Clin Endocrinol, 1995,42( 1 ) :45-50.
7Pinchera A, Wiersinga WM, Glinoer D, et al. Classification of eye changes of Graves' disease[ J ]. Thyroid, 1992,2 (4) : 235.
8Macchia PE, Bagattini M, Lupoli G, et al. High-dose intravenous corticosteroid therapy for Graves' ophthalmopathy[ J]. J Endocrinol Invest,2001,24(3) : 152-158.
9Chang TC, Kao SC, Hsiao YL, et al. Therapeutic responses to corticosteroids in Graves' ophthalmopathy[ J]. J Formos Med Assoc, 1996,95( 11 ) :833-838.
10Marcocci C ,Bartalena L,Tanda ML, et al. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of prospective, single-blind, randomized study [ J]. J Clin Endocrinol Metab,2001,86(8) :3562-3567.
